Company news

InspireMD Inc. news in 2022

InspireMD Inc.'s news releases, calls and decks from 2022, newest first.

View company

InspireMD Announces “12 Days of Carotid Stenting” Video Series Featuring Fireside Chats with Top Multidisciplinary Vascular Specialists

November 27, 2022

InspireMD Announces Multiple Presentations Featuring CGuard EPS and its Novel MicroNet Mesh Covering at the 2022 VEITH Symposium

November 14, 2022

InspireMD Reports Third Quarter 2022 Financial Results and Provides Business Update

November 7, 2022

InspireMD to Report Third Quarter 2022 Financial Results on November 8, 2022, and Provide Corporate Business Update

October 24, 2022

InspireMD Announces Presentation at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) Conference

September 12, 2022

InspireMD Reports Second Quarter 2022 Financial Results and Provides Business Update

August 8, 2022

InspireMD to Report Second Quarter 2022 Financial Results on August 9, 2022, and Provide Corporate Business Update

August 1, 2022

InspireMD Announces Appointment of Endovascular Pioneer Dr. Juan Parodi as Strategic Advisor

July 13, 2022

InspireMD Reports First Quarter 2022 Financial Results and Business Update

May 9, 2022

InspireMD to Report First Quarter 2022 Financial Results on May 10, 2022 and Provide Corporate Business Update

April 27, 2022

InspireMD Reports Fourth Quarter and Year-End 2021 Financial Results

March 7, 2022

InspireMD Announces the Inclusion of its CGuard Carotid Stent in CREST-2 Trial Following FDA Approval of the Investigational Device Exemption Supplement Application

February 27, 2022

InspireMD to Report Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022 and Provide Corporate Business Update

February 21, 2022

InspireMD Announces Adnan Siddiqui, MD, PhD as a Member of its Scientific Advisory Board and Strategic Advisor

February 14, 2022

InspireMD Announces Live Case Broadcast at ISET 2022 Conference Following the Supplement Approval by the FDA Regarding its Pivotal C-Guardians Trial

January 17, 2022

Calls in 2022

Decks in 2022